------and Psychiatry, Albert Einstein College of Medicine, Bronx, NY Heroin (H) abuse during pregnancy has been associated with significantly lower birth weights (BW) in the offspring. Methadone (M) administration during pregnancy has generally resulted in more normally grown neonates. BW of babies born in 1971-2 to groups of mothers with varying histories of narcotic intake were compared. Mean BW of babies born to mothers taking H alone was 2397Gt680 (N=39), and to mothers taking both H and M was 2547Gi656 (N=25)(P>0.05).
Mean BW of babies of mothers who had abused H in the past but were drug-free during the entire pregnancy was 2421Gf430 (N=18); no neonatal withdrawal was seen in this group. Mean BW in this group was no different from the group abusing H during pregnancy (P>0.05), suggesting that H may induce physiologic changes extending beyond the period of addiction.
Mean BW of babies born to mothers taking M alone was 3017Gt524 (N=35). Complete M dosage schedules during pregnancy were available for 20 of these patients. Babies born to mothers taking <70 mglday had a mean BW of 2799Gt478 (N=13) while those >70 mg/day averaged 3539Gt602 (N=7)(P<0.02). A significant linear relationship between M dosage and BW was demonstrated by the calculated regression line (r=.64;P<0.01). This data suggests that M administration during pregnancy appears to correct in a dose-dependent manner heroin-associated fetal growth retardation.
INHIBITION OF FETAL PULMONARY SURFACTANT APPEARANCE AFTER MATERNAL METYRAPONE INFUSION. Robert V. Kotas, LeRoy C. Mims, and Elizabeth J. Trainor, W. K. Warren Med. Res. Ctr., Tulsa, Oklahoma. ( I n t r . by Mary E. Avery) Pulmonary m a t u r i t y w& measured i n f e t a l r a b b i t s a f t e r continuous i n f u s i o n o f metyrapone (M)(7 mglml a t 2 m l l h r x 24 hrs) t o 24 day gestation females and compared t o placebo t r e a t e d c o n t r o l s (C). 27.5 day gestation animals ( t o t a l N = 56) were compared f o r body weight i n gm (BW), wet lung weight expressed as % o f body weight (LW%), mg DNA per lung (DNA), minimal surface tension o f minced l u n g i n dynes per cm (MST), d i s t e n s i b i l i t y expressed as cc per gm o f wet lung a t peak distending P o f 35 cm Hz0 (cclgm), and d e f l a t i o n s t a b i l i t y expressed as % o f maximal volume upon d e f l a t i o n t o a P o f 10 cm Hz0 (%Vmax). A l l r e s u l t s are mean + standard deviat i o n ; * = p < .001.
Decreased %Vmax and increased MST a f t e r M are s i m i l a r t o f i n d i n g s i n 26 day gestation f e t a l r a b b i t s (JAP 30:358, 1971 ). Two a d d i t i o n a l M l i t t e r s delivered a t term (31 days) and 15 o u t o f 17 bunnies survived t o one month o f age. Previously reported ( h e r . Rev. Resp. Dis. 107:1109 , 1973 ) accelerated appearance o f pulmonary surfactant a f t e r i n t e r m i t t e n t metyrapone (300 mg I.M. Q8HX12) may have been due t o incomplete block o f adrenal 11 -6 hydroxylation. Tucker). Deat's. P e~h a n n a c o l o a v T U m a n s a s Sch. o f Med.. ~a n s a s City, Kansas and ~epi". -0 b -~y n , Chas. R. Drew p o s t -~r a d . Med. Sch., Los Angeles.
Placental t r a n s f e r and f e t a l u r i n a r y excretion o f gentam i c i n was studied i n mid-trimester goat and human previable fetuses during constant r a t e maternal i n f u s i o n w i t h the drug. Gentamicin was n o t detected i n the serum o f any o f the goat fetuses, even when maternal serum concentrations ranged from 15.2 ug./ml. t o 20.9 ~g / m l . However, gentamicin was present i n the amniotic f l u i d o f f o u r animals from which f e t a l u r i n e was n o t collected. Gentamicin was also present i n f e t a l u r i n e c o l l e c t e d from three animals. I n contrast, human f e t a l cent r a l venous serum concentrations of gentamicin were 21% t o 37% o f those i n maternal serum f o l l o w i n g constant r a t e i n f u s i o n o f the mother. I n addition, gentamicin was present i n human f e t a l u r i n e i n concentrations two t o three times those i n f e t a l serum. Gentamicin crosses the human placenta more r e a d i l y than the goat placenta and i s concentrated and excreted by the mid-trimester f e t a l kidney. This study i l l u s t r a t e s the inherent danger i n e x t r a p o l a t i n g information obtained from animal studies o f placental t r a n s f e r o f drugs, and emphasizes the need t o conduct c a r e f u l l y designed, confirmatory studies i n human beings. (Supported i n p a r t by USPHS Grant 15956). The metabolism and excretion of orally administered primidone was studied in ten children, ages six to ten years, who were chronically receiving the drug for temporal lobe seizures. Plasma concentrations of primidone (Pr) peaked at 2 to 4 hours and declined exponentially from 6 to 24 hours with half-lives ranging from 6 to 12 hours. A mean of 81% of the administered dose was recovered in the urine as Pr and its metabolites. Of the total Pr excreted in the urine in 24 hours, 53.3% appeared as unchanged drug, 43.8% as phenylethylmalondiamide (PEMA), and 2.9% as phenobarbital (Pb). The rate constants for conversion of Pr to PEMA (Kl), Pr to Pb (Kz), and urinary excretion of unchanged Pr (Kj) were estimated. K1 ranged from .013 to .072 hrs.-l, Kg from .0004 to .005 hrs.-l, and K3 from .058 to .I16 hrs.-l. Those patients with a larger Kq tended to have a higher pllsma concentration of Pb, and vice versa. Since Pb accounts for a small fraction of the total Pr excreted, a ten fold change in K2 will have little influence on the overall rate constant for elimination of primidone, but may have an important effect on the steady state plasma concentration of Pb in patients receiving Pr. rug-protein interaction is of major importance in modulating drug distribution and action in the intact organism. Drug binding to serum proteins in the gravid female is of special interest because of physiological changes during pregnancy which may influence drug activity in the primary host and in the developing fetus. A detailed investigation of salicylate binding to serum albumin during pregnancy was undertaken since aspirin is universally ingested by the pregnant woman and has been implicated as having adverse effects upon the fetus. Serum was obtained from 51 patients taken at their routine examinations during pregnancy and categorized into trimesters. Equilibrium dialysis was performed at 4OC utilizing varying concentrations of sodium salicylate c14 with 1 ml of serum. The apparent association constant (k') of the albuminsalicylate interaction was determined from the construction of Scatchard plots from the data. The mean k' values for lst, 2nd and 3rd trimesters are 3.2, 2.8 and 2.6 x 10~M-l respectively with one mole of salicylate bound at the primary site. These results indicate that there is a decrease in the binding affinity of salicylate for serum albumin as pregnancy progresses. The increased concentrations of free unbound salicylate present during pregnancy would be readily available to diffuse across the placenta and effect the fetus as well as act upon host receptors. The change in binding affinity may result from competitive or allosteric binding by endogenous compounds. 
